Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada for PrEP: A Case Control Study
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 30 Aug 2017 Planned End Date changed from 1 Apr 2018 to 1 Apr 2020.
- 30 Aug 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Apr 2020.
- 10 Jun 2017 Biomarkers information updated